Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-25 @ 9:50 PM
NCT ID:
NCT03151551
Group ID:
EG000
Title:
Ixekizumab
Description:
160 milligrams (mg) ixekizumab (IXE) given subcutaneously (SC) at baseline for all participants.
80 mg ixekizumab given once every 2 weeks (Q2W) SC from week 2 to week 12 and once every 4 weeks (Q4W) thereafter for participants with moderate-to-severe plaque Ps.
80 mg ixekizumab given SC Q4W starting week 4 for participants not meeting criteria for moderate-to-severe plaque Ps.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
283
Other Number Affected:
65
Other Number At Risk:
283
Study:
NCT03151551
Results Section:
NCT03151551
Adverse Events Module:
NCT03151551